These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 18414077)

  • 21. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: one year follow-up after 48 weeks of treatment.
    Aladağ M; Karasu Z; Wright H; Gürakar A
    Turk J Gastroenterol; 2006 Mar; 17(1):35-9. PubMed ID: 16830275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Case of ANCA associated vasculitis induced by interferon therapy for HCV infection].
    Watanabe T; Oono Y; Takeshita E; Kobayashi Y; Tanaka Y; Joko K; Ooshiro Y
    Nihon Shokakibyo Gakkai Zasshi; 2008 Dec; 105(12):1787-93. PubMed ID: 19057165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Consensus and peg-interferon in chronic hepatitis C. Therapy for refractory cases?].
    Kaiser S
    MMW Fortschr Med; 2001 Apr; 143(16):36-7. PubMed ID: 11367991
    [No Abstract]   [Full Text] [Related]  

  • 25. Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.
    Keeffe EB; Dusheiko GM; Tong MJ; Hollinger FB; Heathcote EJ; McHutchison J; Albert D
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):211-6. PubMed ID: 10850385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.
    Keeffe EB; Dusheiko GM; James SP; Mullen KD; Everson GT; Pimstone NR; Donovan J; Albert D
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):207-10. PubMed ID: 10850384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the efficacy of combined therapy with interferon alfacon-1 and ribavirin for chronic hepatitis C].
    Horban A; Wasilewski M; Berak H; Stańczak JJ; Bardadin K; Paprocka H
    Przegl Epidemiol; 2006; 60(3):563-9. PubMed ID: 17249181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.
    da Silva LC; Bassit L; Ono-Nita SK; Pinho JR; Nishiya A; Madruga CL; Carrilho FJ
    J Gastroenterol; 2002; 37(9):732-6. PubMed ID: 12375147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study of interferon-alpha high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C.
    Berg T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2001 Feb; 39(2):145-51. PubMed ID: 11253505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Observation on the efficacy and safety of Infergen combined with capsule ribavirin in treatment of hepatitis C patients].
    Luo GH; Liao BM; Huang SB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):363. PubMed ID: 15225435
    [No Abstract]   [Full Text] [Related]  

  • 32. Anosmia induced with alpha interferon in a patient with chronic hepatitis C.
    Kraus I; Vitezic D
    Int J Clin Pharmacol Ther; 2000 Jul; 38(7):360-1. PubMed ID: 10919345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load.
    Tsubota A; Arase Y; Suzuki F; Suzuki Y; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kumada H
    J Gastroenterol; 2004; 39(2):155-61. PubMed ID: 15069622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.
    Steffen M; Cornberg M; Buggisch P
    Hepatogastroenterology; 2007 Dec; 54(80):2368-72. PubMed ID: 18265667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus interferon induced interstitial pneumonitis in a patient with HCV.
    Hillier AE; Mand J; Raza A; Markov M; Nadir A
    Am J Gastroenterol; 2006 Jan; 101(1):200-2. PubMed ID: 16405558
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.
    Bonkovsky HL; Woolley JM
    Hepatology; 1999 Jan; 29(1):264-70. PubMed ID: 9862876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interferon alpha, gamma, omega before and during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin].
    Bolewska B; Czajka A; Moczko J; Juszczyk J
    Przegl Epidemiol; 2007; 61(4):755-63. PubMed ID: 18572508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature].
    Alfageme Michavila I; Merino Sánchez M; Pérez Ronchel J; Lara Lara I; Suárez García E; López Garrido J
    Arch Bronconeumol; 2004 Jan; 40(1):45-9. PubMed ID: 14718122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.